Research and applications across a range of disease areas to improve allocative efficiency (the maximisation of health outcomes using the most cost-effective mix of interventions and implementation methods).
Optima models have been used extensively to address investment choices related to numerous areas including HIV/AIDS, tuberculosis, malaria, viral hepatitis, and nutrition.
Modelling groups affiliated with the Optima Consortium are continuing to extend the Optima approach, by developing new applications to inform investment of publicly-funded benefits packages for entire health systems, and for optimising implementation options across diverse sectors.
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present. We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
Oops!
It looks like something may have gone wrong, and some of the resources required to load the page may not have loaded correctly.
